Top compounds associated with response to SIRT2


Feature Type Standardized
Nominal ANOVA
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA NSC 74859 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA AUY922 GDSC1000 pan-cancer AAC -0.16 4e-06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 7e-06
Download CSV